| Year |
Citation |
Score |
| 2020 |
Shahid M, Qadir A, Yang J, Ahmad I, Zahid H, Mirza S, Windisch MP, Shahzad-Ul-Hussan S. An Engineered Microvirin Variant with Identical Structural Domains Potently Inhibits Human Immunodeficiency Virus and Hepatitis C Virus Cellular Entry. Viruses. 12. PMID 32054060 DOI: 10.3390/V12020199 |
0.305 |
|
| 2019 |
Martinez PJ, Farhan A, Mustafa M, Javaid N, Darkoh C, Garrido-Sanabria E, Fisher-Hoch SP, Briles DE, Kantarci A, Mirza S. PspA facilitates evasion of pneumococci from bactericidal activity of neutrophil extracellular traps (NETs). Microbial Pathogenesis. 103653. PMID 31398527 DOI: 10.1016/J.Micpath.2019.103653 |
0.583 |
|
| 2016 |
Mirza S, Benjamin WH, Coan PA, Hwang SA, Winslett AK, Yother J, Hollingshead SK, Fujihashi K, Briles DE. The effects of differences in pspA alleles and capsular types on the resistance of Streptococcus pneumoniae to killing by apolactoferrin. Microbial Pathogenesis. PMID 27569531 DOI: 10.1016/J.Micpath.2016.08.029 |
0.707 |
|
| 2015 |
André GO, Politano WR, Mirza S, Converso TR, Ferraz LF, Leite LC, Darrieux M. Combined effects of lactoferrin and lysozyme on Streptococcus pneumoniae killing. Microbial Pathogenesis. 89: 7-17. PMID 26298002 DOI: 10.1016/J.Micpath.2015.08.008 |
0.49 |
|
| 2013 |
Kruzel ML, Actor JK, Zimecki M, Wise J, Płoszaj P, Mirza S, Kruzel M, Hwang SA, Ba X, Boldogh I. Novel recombinant human lactoferrin: differential activation of oxidative stress related gene expression. Journal of Biotechnology. 168: 666-75. PMID 24070904 DOI: 10.1016/J.Jbiotec.2013.09.011 |
0.329 |
|
| 2013 |
Daniels CC, Kim KH, Burton RL, Mirza S, Walker M, King J, Hale Y, Coan P, Rhee DK, Nahm MH, Briles DE. Modified opsonization, phagocytosis, and killing assays to measure potentially protective antibodies against pneumococcal surface protein A. Clinical and Vaccine Immunology : Cvi. 20: 1549-58. PMID 23925886 DOI: 10.1128/Cvi.00371-13 |
0.702 |
|
| 2012 |
Mukerji R, Mirza S, Roche AM, Widener RW, Croney CM, Rhee DK, Weiser JN, Szalai AJ, Briles DE. Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine. Journal of Immunology (Baltimore, Md. : 1950). 189: 5327-35. PMID 23105137 DOI: 10.4049/Jimmunol.1201967 |
0.66 |
|
| 2011 |
Mirza S, Wilson L, Benjamin WH, Novak J, Barnes S, Hollingshead SK, Briles DE. Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin. Infection and Immunity. 79: 2440-50. PMID 21422179 DOI: 10.1128/Iai.00489-10 |
0.503 |
|
| 2007 |
Senkovich O, Cook WJ, Mirza S, Hollingshead SK, Protasevich II, Briles DE, Chattopadhyay D. Structure of a complex of human lactoferrin N-lobe with pneumococcal surface protein a provides insight into microbial defense mechanism. Journal of Molecular Biology. 370: 701-13. PMID 17543335 DOI: 10.1016/J.Jmb.2007.04.075 |
0.601 |
|
| 2006 |
Daniels CC, Briles TC, Mirza S, Håkansson AP, Briles DE. Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae. Microbial Pathogenesis. 40: 228-33. PMID 16540281 DOI: 10.1016/J.Micpath.2006.01.007 |
0.725 |
|
| 2003 |
Briles DE, Hollingshead SK, Crain MJ, Ren B, Mirza S, Watt J, Johnston J. Pneumococcal proteins that may constitute the next generation vaccine for pneumococcal disease International Congress Series. 1257: 27-31. DOI: 10.1016/S0531-5131(03)01157-9 |
0.571 |
|
| 2001 |
Håkansson A, Roche H, Mirza S, McDaniel LS, Brooks-Walter A, Briles DE. Characterization of binding of human lactoferrin to pneumococcal surface protein A. Infection and Immunity. 69: 3372-81. PMID 11292760 DOI: 10.1128/Iai.69.5.3372-3381.2001 |
0.701 |
|
| Show low-probability matches. |